An overview of drug-induced liver injury

Journal for Nurse Practitioners

Volumn 7, Issue 10, 2011, Pages 819-826

  Thanavaro, Joanne L ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

Causality assessment method; Cholestatic injury; Direct hepatotoxicity; Drug induced liver injury; Hepatocellular injury; Idiosyncratic immune reaction; Mixed injury

Indexed keywords

EID: 83455201264     PISSN: 15554155     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurpra.2011.07.007     Document Type: Article

References (36)

1. Ghabril M, Chalasani N, Björnsson E Drug-induced liver injury: a clinical update. Curr Opin Gastroentrol 2010, 26:222-226.
2. Ramachandran R, Kakar S Histological patterns in drug-induced liver disease. J Clin Pathol 2009, 62:481-492.
3. Watkins PB, Seeff LB Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology 2006, 43:618-631.
4. Hinson JA, Roberts DW, James LP Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol 2010, 196:369-405.
5. Navarro VJ, Senior JR Drug related hepatotoxicity. N Engl J Med 2006, 354:731-739.
6. Rueben A, Koch A, Lee W, the Acute Liver Failure Study Group Drug-induced acute liver failure: Results of a U.S. multicenter, prospective study. Hepatology 2010, 52:2065-2067.
7. Andrade RJ, Lucena MI, Fernández MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish Registry over a 10-year period. Gastroenterology 2005, 129(2):512-521.
8. Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, for the DILIN Study Group, et al. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Safety 2009, 32:55-68.
9. Li B, Wang Z, Fang JJ, Xu CY, Chen WX Evaluation of prognostic markers in severe drug-induced liver disease. World J Gastroenterol 2007, 13:628-632.
10. Wei G, Bergqist A, Broomé, Lindgren S, Wallerstedt S, Almer S, et al. Acute liver failure in Sweden: etiology and outcome. J Intern Med 2007, 262:393-401.
11. Andrade RJ, Agúndez JAG, Lucena MI, Martinez C, Cueto R, Garcia-Martin E Pharmacogenomics in drug induced liver injury. Curr Drug Metab 2009, 10:956-970.
12. Liu ZX, Kaplowitz N Immune-mediated drug-induced liver disease. Clin Liver Dis 2002, 6:467-486.
13. Gunawan BK, Kaplowitz N Mechanisms of drug-induced liver disease. Clin Liver Dis 2007, 11:459-475.
14. Holt MP, Ju C Mechanisms of drug-induced liver injury. AAPS J 2006, 8:E48-E54.
15. Lammert C, Einarsson S, Saha C, Niklasson A, Bijornsson E, Chalasani N Relationship betweendaily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals. Hepatology 2008, 47:2003-2009.
16. Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, et al. Clinical advances in liver, pancreas, and biliary tract: causes, clinical features, and outcome from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008, 135:1924-1934.
17. Zimmerman HJ Drug-induced liver disease. Clin Liver Dis 2000, 4:73-96.
18. Teschke R, Schwarzenboeck A, Hennermann KH Causality assessment in hepatotoxicity by drug and dietary supplements. Br J Clin Pharm 2008, 66:758-766.
19. The Merck Manuals Liver injury caused by drugs Accessed January 9, 2011. http://www.merckmanuals.com/professional/sec03/ch024/ch024c.html.
20. Food and Drug Administration Guidance for Industry (Draft) Drug-Induced Liver Injury: Premarketing Clinical Evaluation Accessed April 17, 2011. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072278.pdf.
21. Possuelo LG, Castelan JA, de Brito TC, Ribeiro AW, Cafrune PI, Picon PD, et al. Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil. Eur J Clin Pharmacol 2008, 64:673-681.
22. Lawrenson RA, Seaman HE, Sunström A, William TJ, Farmer RD Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data. Drug Safety 2000, 23:333-349.
23. Ramakrishna J, Johnsons AR, Banner BF Long-term minocycline use for acne in healthy adolescents can cause severe autoimmune hepatitis. J Clin Gastroenterol 2009, 43:787-790.
24. Bessone F Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?. World J Gastroenterol 2010, 16:5651-5661.
25. Laine L, Goldkind L, Curtis SP, Connors LG, Yanqiong Z, Cannon CP How common is Diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial. Am J Gastroenterol 2009, 104:356-362.
26. O'Connor N, Dargan PI, Jones AL Hepatocellular damage from non-steroidal anti-inflammatory drugs. Q J Med 2003, 96:787-791.
27. Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005, 42:1364-1372.
28. Mills EJ, O'Regan C, Eyawo O, Wu P, Mills F, Berwanger O, et al. Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of > 40 000 patients. Eur Heart J 2011, 32:1409-1415.
29. Cohen DE, Anania FA, Chalasani N An assessment of statin safety by hepatologists. Am J Cardiol 2006, 97(suppl):77C-81C.
30. Russo MW, Scobey M, Bonkovsky HL Drug-induced liver injury associated with statins. Semin Liver Dis 2009, 29:412-422.
31. Graham DJ, Green L, Senior JR, Nourjah P Troglitazone-induced liver failure: a case study. Am J Med 2003, 114:299-306.
32. Ikeda T Drug-induced idiosyncratic hepatotoxicity: prevention strategy developed after the troglitazone case. Drug Metab Pharmacokinet 2011, 26:60-70.
33. Chalasani N, Teal E, Hall SD Effect of Rosiglitazone on serum liver chemistries in diabetic patients with normal and elevated baseline liver enzymes. Am J Gastroenterol 2005, 100:1317-1321.
34. Lutchman G, Modi A, Kleiner DF, Promrat K, Heller T, et al. The effects of discontinuing Pioglitazone in patients with nonalcoholic steatohepatitis. Hepatology 2007, 46:424-429.
35. Lee WM, Senior JR Recognizing drug-induced liver injury: current problems, possible solutions. Toxicologic Pathol 2005, 33:155-164.
36. Bleibel W, Kim S, D'silva K Drug-induced liver injury: Review article. Dig Dis Sci 2007, 52:2463-2471.